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Abstract
Increased low-density lipoprotein (LDL) cholesterol is a recognized risk factor for atherosclerosis. There is also strong
evidence that oxidatively modified LDL initiates the development of this pathological process and the administration of
antioxidants might have a protective effect. However, the appropriate trials did not provide completely consistent results. We
found in this study that the oxidation kinetics and also the antioxidant effectiveness are different depending on the
cholesterol content in LDL. Higher cholesterol in LDL causes an acceleration of its oxidation as well as an increase of
resistance to the antioxidative effect of ascorbic acid. In searching for a theoretical background of this dual impact of
cholesterol in LDL, computer simulation of LDL oxidation was used. It was found that the pre-existing level of lipid
hydroperoxides together with the total amount of oxidizable lipid substrate associated with the cholesterol level in LDL were
satisfactory prerequisites for a best fit to the experimental data. In conclusion, this study provides at least a partial
explanation for some failures to arrest, by administration of antioxidants, the progression of atherosclerosis in animal and
human hypercholesterolemia. ß 1999 Elsevier Science B.V. All rights reserved.
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An increased concentration of plasma low-density
lipoprotein (LDL) cholesterol constitutes a major
risk factor for atherosclerosis and cardiovascular dis-
ease. Several lines of evidence support a role for ox-
idatively modi¢ed LDL in atherosclerosis and for its
in vivo existence [1]. Antioxidants have been shown
to decrease atherosclerotic lesion formation in some
[2] but not in all animal models especially when cho-
lesterol levels remained markedly elevated [3^7].
During our studies aimed at elucidating the relation
between cholesterol and oxidation kinetics of LDL
[8,9] we noticed that the same amount of antioxidant
added to various LDL samples had variable impact
on LDL oxidizability. This e¡ect apparently corre-
lated negatively with the content of LDL cholesterol.
Therefore, we undertook a more detailed analysis
because of possible linkage of this e¡ect to the above
mentioned discrepancies.
Isolation of LDL from human serum of volunteers
and copper catalyzed oxidation was carried out as
described earlier [9]. The oxidation of LDL was fol-
lowed according to the absorbance change at 234 nm
corresponding to conjugated dienes during 5^24 h
(see [10]). The absorption was set to zero at the be-
ginning of the reaction. The ascorbic acid was added
immediately before oxidation of the LDL samples.
The addition of ascorbic acid caused a prolongation
in lag time of oxidation as expected [10,11] but to
0925-4439 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 9 8 ) 0 0 1 0 0 - 8
BBADIS 60070 28-12-98
Biochimica et Biophysica Acta 1453 (1999) 180^184
various extents (Fig. 1). The samples were therefore
allocated to groups H, M and L. In group H the
e¡ect of ascorbic acid was very small or almost neg-
ligible, the related level of LDL cholesterol was 4.1
mmol l31 and the initial lag time was 59.4 min. In
group M the e¡ect of ascorbic acid was intermediate,
the LDL cholesterol was 3.2 mmol l31 and the initial
lag time was 84 min. In group L the lag time was
most prolonged ending not before 7 h due to ascor-
bic acid, LDL cholesterol was 1.9 mmol l31 and the
initial lag time was 202.8 min. In all groups the pro-
tein content was close to 100 Wg ml31 of sample.
The basic reactions used by the simulation are de-
scribed in Table 1. The regression analysis and ana-
lytical integration were carried out with a computer-
aided program, Origin 4.1 (MicroCal Software) and
Matlab 4 (The Math Works), respectively. The pro-
gram used for numerical integration of di¡erential
equations related to the mass action kinetics of
Table 1 was the GEPASI package of Windows 95,
version 3.1 [12,13]. The average computing time for a
full reaction set was less than 0.5 s for a real time of
8 h. This program was unique in providing reliable
solutions to many problems involving di¡erential
equation sets.
The time courses of LDL oxidation in group H, M
and L are depicted in Fig. 1.
Data (average from three experiments) marked by
squares, diamonds and circles correspond to controls
and 2.25 or 4.5 Wmol l31 concentration of ascorbic
acid added to the LDL samples. One can see the
remarkable di¡erence in lag phase and antioxidant
e¡ectiveness between the di¡erent groups of LDL
samples.
There is no straightforward explanation for the
above mentioned phenomenon because the oxidation
of LDL is relatively complex and a tightly ordered
process even under in vitro conditions [14]. Never-
theless, the problem can be accessible with the help
of some simulation models (e.g. [15,16]). Basic ele-
mentary reactions are listed in Table 1. Those num-
bered 1 and 2 can be solved analytically. It leads to
the equation
LOOH  LHULOOHi= LOOHi3exp
3kULHUtimeULOOHi  exp
3kULHUtimeULH;
where k is constant, [LOOH]i is the initial concen-
tration of LOOH (see also Table 1). The equation
was used for the regression of experimental data that
provided ¢rst estimates of maximum and initial val-
ues of LOOH in the groups given in Table 1.
Numerical integration of all reactions 1, 2, 3 and 4
expressed as a set of simultaneous di¡erential equa-
tions of the ¢rst order proved to be more informa-
tive. The exploration of the best ¢t of the model to
experimental data by scanning of ‘parameters space’
and experimentation with the model showed that the
preformed level of lipid peroxides alone (see LOOH
in reaction 1) was the main determinant of oxidation
Fig. 1. The time course of oxidation of human LDL of various
cholesterol contents and e¡ect of ascorbic acid. Symbols repre-
sent the experimental data and the lines the simulation data.
Data marked by squares and/or by line 1 correspond to the
control, whereas data marked by diamonds, circles and/or lines
2 and 3 were obtained in the presence of increasing concentra-
tion of ascorbic acid. For more details, see the text.
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susceptibility and e¡ectiveness of antioxidant. This
agrees with the experimental ¢ndings that the manip-
ulation of the amount of preformed LOOH dramat-
ically changes the lag time [8,17,18]. The length of
the lag phase was linearly and negatively related to
the logarithm of LOOH concentration. As a corol-
lary of this ¢nding, the e¡ect of antioxidant in-
creased exponentially with its dose but it was almost
negligible when the level of preformed LOOH was
high. The raising constant of reaction 2 in£uences
positively the rate of the propagation phase. Reac-
tion 3 describes a requirement of LDL oxidation for
oxygen. The model agrees with the fact that the oxy-
gen concentration in the laboratory is not rate limit-
ing for LDL oxidation. It predicts, however, that
increasing lack of oxygen might play an important
role in the defence mechanism against LDL oxida-
tion. Reaction 4 describes the scavenging of LOOc
radicals by antioxidant (AH) yielding LOOH and
antioxidant radicals Ac. The computed data are pre-
sented as lines numbered 1, 2, 3 for the indicated
experimental groups H, M and L in Fig. 1. The dif-
ference between experimental and simulated data ex-
pressed in currently accepted parameters (lag time,
half time, rate and the extent of oxidation using
the same ¢tting sigmoidal function, see [9]) was
about 4% on average.
This study supports some of the earlier observa-
tions that cholesterol rich LDL and/or hypercholes-
terolemia accelerates the initial phase of LDL oxida-
tion [19^21]. This paper shows, in addition, the
existence of a negative correlation between the level
of LDL cholesterol and antioxidant e¡ect of ascorbic
acid. The simulation model indicates that the de-
creasing antioxidant defence is not directly related
to the raising cholesterol content in LDL but rather
to its oxidizable component (see LH in Table 1) and
to the increasing concentration of preformed lipid
hydroperoxides [22,23]. The association between
these two variables was observed earlier under vari-
ous conditions [24^26]. It was also found that pre-
formed lipid hydroperoxides decrease due to admin-
istration of antioxidants in vitro as well as in vivo
[11,27]. It should be noted that the variable e¡ect
described here was not speci¢c for ascorbic acid
but it was found also when using other antioxidants
of the polyphenolic type (see [28^30]).
This study may explain why in some works the
administration of antioxidant failed to stop the de-
velopment of atherosclerosis especially under the ex-
istence of higher cholesterolemia [3,5], because
hypercholesterolemia, albeit indirectly increases re-
sistance to the antioxidant e¡ect. However, it re-
mains unclear why in other papers such failure was
accompanied by the prolongation of the lag phase of
LDL oxidation [4,6]. The simulation model of LDL
oxidation with no additional data can o¡er only few
general explanations. It is obvious that atherosclero-
Table 1
Reactions, rate constants and metabolites initial values used by simulating the LDL oxidation
Reaction no. Rate constants (M31 s31)
Group H Group M Group L
A0 A1 A2 A0 A1 A2 A0 A1 A2
Cu(II)/Cu(I)
1. LOOHCLOOc 1U1037 1U1037 1U1037 1U1037 1U1037 1U1037 1.5U1037 1U1037 1U1037
2. Lh+LOOcCLOOH+Lc 8 8 8 18 19 18 4.8 4.8 4.8
3. Lc+O2CLOOc 3U108 3U108 3U108 3U108 3U108 3U108 3U108 3U108 3U108
4. Ah+LOOcCAc+LOO 920 920 920 920 920 920 920 920 920
The experimentally found constants (see [15]) were slightly modi¢ed for best ¢t to the experimental data of group H, M and L de-
scribed in the text. Each group comprised three sets A0, A1 and A2 corrresponding to the increasing amount of ascorbic acid added
to the LDL samples.
The initial values of LOOH (a.u.) for the sets A0, A1 and A2 in group H were: 0.027, 0.03, 0.033, in group M: 0.002, 0.002, 0.002
and in group L: 0.001, 0.0005, 0.0005, respectively. The values of Lh (a.u.) for all the groups H, M and L were: 0.86, 0.85 and 0.42,
respectively. The initial values of radicals LOOc, Lc and Ac were set to zero and the ¢xed value of oxygen was set to 0.0001 M for all
models. For Ah it was in all sets (in M): 1U1036 (assumed amount of endogenous antioxidant), 3.2U1036 and 5.5U1036.
Abbreviations: LOOH, lipid hydroperoxides; LOOc, lipid peroxyl radical ; Lh, oxidizable lipid or PUFA; Lc, free lipid radical; O2,
oxygen; Ah, antioxidant, ascorbic acid; Ac, radical Ah; Cu(II)/Cu(I), copper-catalyzed reaction; a.u., absorption units.
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sis development in vivo is a¡ected by many determi-
nants including the continuous production of oxidiz-
able lipids. Some of them most likely do not exist
during the in vitro test for LDL oxidation [31]. The
preformed lipid hydroperoxides due to intensive anti-
oxidant therapy could remain low under ex vivo
conditions resulting in high resistance of LDL to
oxidation, whereas under conditions in vivo other
determinants of LDL oxidation could predominate.
The simulation model predicts, for example, that the
e¡ect of a 10-fold increased concentration of antiox-
idant could be eliminated by a 3-fold greater rate
constant of reaction 1 or, by a 2-fold greater rate
constant of reactions 1 and 2.
It should be remembered, in addition, that the
relative increase of cholesterolemia experimentally in-
duced is usually much higher and of shorter duration
than that in man. Thus, other conditions for athero-
sclerosis development could be initiated [32^34].
Remembering this, the possible clinical implica-
tions include the importance of decreasing the oxi-
dizable lipid substrate and increasing exponentially
antioxidant doses to achieve protection against
LDL oxidation.
The author wishes to thank Mrs. M. Pilatova for
her expert technical assistance. The work was sup-
ported by a grant from the Ministry of Health,
Prague, Czech Republic.
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